Dr Reddy's laboratories, Cipla and Aurobindo Pharma are among 11 firms that may acquire 79 existing and future drugs from Teva Pharmaceuticals as part of the condition set by the US Federal Trade Commission for $40.5 billion Teva-Allegran deal.
Ajanta Pharma has received nod from the US health regulator for generic Omeprazole and sodium bicarbonate powder for oral suspension used for treatment of stomach and esophagus problems such as ulcers and acid reflux.
Drug major Sun Pharmaceutical and Spanish firm Almirall have entered into a licensing pact for development and commercialisation of tildrakizumab used for treatment of psoriasis in Europe.
Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma - backed by KKR & Co LP - for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound acquisition this year.
Drug major Sun Pharmaceutical Industries is recalling over 16,000 bottles of anti-depressant tablets from the US market due to failed dissolution specifications.
Drug firm RPG Life Sciences on Wednesday inked a pact to acquire seven prescription brands from Sun Pharmaceutical Industries for a consideration of Rs 41 crore.
The government said it has raised FDI limit in existing pharmaceutical companies to attract required capital, international best practices and latest technologies in the sector.
Shanghai Fosun Pharmaceutical (Group) Co will sign a definitive agreement on Wednesday to buy a controlling stake in India's Gland Pharma in a $1.4 billion deal, the Economic Times newspaper reported, citing a source with direct knowledge.
Glenmark Pharmaceuticals has received final approval from the US health regulator for Potassium Chloride Extended Release Tablets, used in treating low levels of potassium in blood.
Biocon's contract research arm Syngene International has lined up $200 million (around Rs 1,342 crore) capex to bolster its manufacturing capabilities over the next three years.
Drug firm Wockhardt on Thursday said the US Food and Drug Administration (FDA) has made "observations" in its Establishment Inspection Report (EIR) for the company's three units in Maharashtra and a ban on exports from the facilities to the US will continue.
Drug firm Suven Life Sciences said it has received the Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant near Hyderabad.
Drug firm Lupin has launched its generic oral contraceptive Norgestimate and ethinyl estradiol tablets in the American market after receiving nod from the US health regulator.
The government has not given a nod to any pharma firm to increase prices of drugs beyond permissible limits, Parliament was informed on Tuesday.
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules, used in the treatment of acid reflux and ulcers, in the American market after receiving final approval from the US Food and Drug Administration (FDA).
Dr Reddy's Laboratories (DRL) expects complex generics and proprietary products, including creation of a branded generics platform in the US, to be the main drivers of its growth going forward.
Drug firm Cadila Healthcare's US arm Zydus Pharmaceuticals (USA) Inc will start selling a generic version of Asacol HD, used for treatment of ulcerative colitis, in the American market from August 1, 2016.
The pharmaceuticals sector may report strong revenue growth for the first quarter of the current fiscal year, foreign brokerage Jefferies has said in a report.
Dishman Pharmaceuticals and Chemicals has received an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for three of its facilities.
Pharmaceuticals major Dr Reddy's Laboratories is recalling 9,330 bottles of Sirolimus tablets, used for prevention of organ rejection after kidney transplant, in the US due to presence of impurities.